✦ LIBER ✦

Phase II trial of gemcitabine as second line therapy for non-small cell lung cancer (NSCLC)

✍ Scribed by Gillenwater, HH; Tynan, M; Socinski, MA

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial testing gemcitabine as

✍ Sculier, J.P; Lafitte, J.J; Berghmans, T; Thiriaux, J; Lecomte, J; Efremidis, A; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 77 KB

A multicenter phase II trial with gemcit

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Phase II trial of weekly docetaxel (D) i

✍ Lilenbaum, R; Schwartz, M; Siegel, L; Belette, F; Blaustein, A; Wittlin, F; Cisn 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Second-Line Gemcitabine in Refractory St

✍ Heidi H. Gillenwater; Maureen Tynan; Susan Natoli; Michael J. Schell; Mark A. So 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 135 KB

Phase II study of gemcitabine in non sma

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Gemcitabine (GEM) as single agent in sec

✍ Mahjoubi, R; Llory, J.F; Brugière, O; Vannetzel, J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB